Allergic Comorbidity Is a Risk Factor for Not Attending Scheduled Outpatient Visits in Children with Asthma

Kalle Garpvall1, Marie Hauerslev1, Mads Marckmann1

  • 1Department of Pediatric and Adolescent Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, 2730 Copenhagen, Denmark.

Insights

Children with asthma and allergic sensitization are more likely to miss appointments. Atopic predisposition may reduce missed visits. This study identifies key factors influencing attendance in pediatric asthma care.

Area of Science:

  • Pediatric Pulmonology
  • Allergy and Immunology

Background:

  • Asthma is a prevalent chronic childhood illness.
  • Missed primary care visits are linked to poor treatment adherence and short-term asthma control loss.
  • Long-term non-attendance patterns in pediatric asthma care require further investigation.

Purpose of the Study:

  • To examine long-term patterns of missed outpatient visits in children with asthma.
  • To identify predictors of non-attendance over a 5-year period.
  • To assess the association between non-attendance and asthma control or treatment adherence.

Main Methods:

  • Longitudinal study of 146 children with asthma over 5 years.
  • Analysis of scheduled outpatient visit attendance records.
  • Multivariate analysis to identify risk factors for non-attendance, including allergic sensitization, atopic predisposition, asthma treatment step, and lung function.

Main Results:

  • 46% of children missed at least one appointment, totaling 10.8% of all scheduled visits.
  • Allergic sensitization was a significant risk factor for non-attendance (aOR = 6.6).
  • Atopic predisposition decreased the risk of non-attendance (aOR = 0.36).
  • No association was found between non-attendance and treatment adherence or loss of asthma control.

Conclusions:

  • Allergic comorbidity, not asthma severity, predicts non-attendance in pediatric asthma care.
  • Children with allergic sensitization represent a group at higher risk for missed appointments.
  • Understanding these predictors can inform strategies to improve appointment adherence in pediatric asthma management.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
2.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
812
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
662